Quest Diagnostics Inc Restructuring and Related Cost, Expected Number of Positions Eliminated
Quest Diagnostics Inc (DGX) reported Restructuring and Related Cost, Expected Number of Positions Eliminated of 500 positions for the 9-month period ending 2013-09-30, per its 10-Q filed 2013-10-24.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated · last filed 2013-10-24
- 2013-09-30: Restructuring and Related Cost, Expected Number of Positions Eliminated 9 month 500.00 positions.
- 2013-06-30: Restructuring and Related Cost, Expected Number of Positions Eliminated 6 month 500.00 positions.
| Period end | Restructuring and Related Cost, Expected Number of Positions Eliminated 6 month | Restructuring and Related Cost, Expected Number of Positions Eliminated 9 month |
|---|---|---|
| 2013-09-30 | 500.00 positions 10-Q · filed 2013-10-24 | |
| 2013-06-30 | 500.00 positions 10-Q · filed 2013-07-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |